China Pharma Holdings (CPHI) Capital Expenditures Growth (1y) (2011 - 2025)
China Pharma Holdings (CPHI) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 32.28% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 3,566.67% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 113.56% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -14.95% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -21.54% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -59.55% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -76.65% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 4,261.59% |
| 10 | China Pharma Holdings | 18.56 Mn | 18.39 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -97.68% |
| Sep 30, 2025 | 106.63% |
| Dec 31, 2024 | 331.74% |
| Sep 30, 2024 | -113.67% |
| Dec 31, 2023 | 116.60% |
| Sep 30, 2023 | -73.29% |
| Jun 30, 2023 | -102.57% |
| Mar 31, 2023 | -4,123.29% |
| Dec 31, 2022 | -486.45% |
| Sep 30, 2022 | -39.29% |
| Dec 31, 2021 | 103.03% |
| Sep 30, 2021 | 60.34% |
| Dec 31, 2020 | -562.70% |
| Sep 30, 2020 | 2,026.29% |
| Jun 30, 2020 | 150,299.39% |
| Mar 31, 2020 | 370.85% |
| Dec 31, 2019 | 182.18% |
| Sep 30, 2019 | 264.21% |
| Jun 30, 2019 | -101.24% |
| Mar 31, 2019 | 1,936.56% |